Axa’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-295,926
Closed -$1.98M 1363
2017
Q4
$1.98M Sell
295,926
-399,056
-57% -$2.67M 0.01% 865
2017
Q3
$5.69M Sell
694,982
-172,479
-20% -$1.41M 0.02% 591
2017
Q2
$3.9M Sell
867,461
-32,539
-4% -$146K 0.02% 664
2017
Q1
$4.96M Buy
+900,000
New +$4.96M 0.02% 595